Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth

Human Molecular Genetics

Volumn 16, Issue 9, 2007, Pages 1098-1112

  Daginakatte, Girish C ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; COLONY STIMULATING FACTOR 1; HEPARIN; HYALURONIDASE; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROFIBROMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN; BRAIN TUMOR; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA FINGERPRINTING; DNA MICROARRAY; DRUG INHIBITION; EMBRYO DEVELOPMENT; ENZYME INHIBITION; GENE ACTIVATION; GENE MUTATION; GENE TARGETING; GENETIC ENGINEERING; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MICROENVIRONMENT; MICROGLIA; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTIC NERVE GLIOMA; PARACRINE SIGNALING; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD44; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIOMA; HETEROZYGOTE; HUMANS; HYALURONOGLUCOSAMINIDASE; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MINOCYCLINE; NEUROFIBROMIN 1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 34447320760     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm059     Document Type: Article

References (71)

1. Friedman, J.M. (1999) Epidemiology of neurofibromatosis type 1. Am. J. Med. Genet., 89, 1-6.
2. Korf, B.R. (1999) Plexiform neurofibromas. Am. J. Med. Genet., 89, 31-37.
3. Viskochil, D.H. (2003) It takes two to tango: Mast cell and Schwann cell interactions in neurofibromas. J. Clin. Invest., 112, 1791-1793.
4. Listernick, R., Darling, C., Greenwald, M., Strauss, L. and Charrow, J. (1995) Optic pathway tumors in children: The effect of neurofibromatosis type 1 on clinical manifestations and natural history. J. Pediatr. 127, 718-722.
5. Listernick, R., Charrow, J., Greenwald, M. and Mets, M. (1994) Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study. J. Pediatr., 125, 63-66.
6. Kleihues, P., Louis, D.N., Scheithauer, B.W., Rorke, L.B., Reifenberger, G., Burger, P.C. and Cavenee, W.K. (2002) The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol., 61 215-225.
7. Listernick, R., Louis, D.N., Packer, R.J. and Gutmann, D.H. (1997) Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the Nf1 Optic Pathway Glioma Task Force. Ann. Neurol. 41, 143-149.
8. Gutmann, D.H., Rasmussen, S.A., Wolkenstein, P., MacCollin, M.M., Guha, A., Inskip, P.D., North, K.N., Poyhonen, M., Birch, P.H. and Friedman, J.M. (2002) Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (Nf1). Neurology, 59, 759-761.
9. King, A., Listernick, R., Charrow, J., Piersall, L. and Gutmann, D.H. (2003) Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome. Am. J. Med. Genet. A, 122, 95-99.
10. Thiagalingam, S., Flaherty, M., Billson, F. and North, K. (2004) Neurofibromatosis type 1 and optic pathway gliomas: Follow-up of 54 patients. Ophthalmology, 111, 568-577.
11. Bajenaru, M.L., Zhu, Y., Hedrick, N.M., Donahoe, J., Parada, L.F. and Gutmann, D.H. (2002) Astrocyte-specific inactivation of the neurofibromatosis 1 gene (Nf1) is insufficient for astrocytoma formation. Mol. Cell. Biol., 22, 5100-5113.
12. Bajenaru, M.L., Hernandez, M.R., Perry, A., Zhu, Y., Parada, L.F., Garbow, J.R. and Gutmann, D.H. (2003) Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res., 63, 8573-8577.
13. Bajenaru, M.L., Garbow, J.R., Perry, A., Hernandez, M.R. and Gutmann, D.H. (2005) Natural history of neurofibromatosis 1-associated optic nerve glioma in mice. Ann. Neurol., 57, 119-127.
14. Zhu, Y., Harada, T., Liu, L., Lush, M.E., Guignard, F., Harada, C., Burns, D.K., Bajenaru, M.L., Gutmann, D.H. and Parada, L.F. (2005) Inactivation of Nf1 in CNS causes increased glial progenitor proliferation and optic glioma formation. Development., 132, 5577-5588.
15. Roggendorf, W., Strupp, S. and Paulus, W. (1996) Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol. (Berl.), 92, 288-293.
16. Badie, B. and Schartner, J.M. (2000) Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 46, 957-961.
17. Streit, W.J., Conde, J.R., Fendrick, S.E., Flanary, B.E. and Mariani, C.L. (2005) Role of microglia in the central nervous system's immune response. Neurol. Res., 27, 685-691.
18. Platten, M., Kretz, A., Naumann, U., Aulwurm, S., Egashira, K., Isenmann, S. and Weller, M. (2003) Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann. Neurol., 54, 388-392.
19. Markovic, D.S., Glass, R., Synowitz, M., Rooijen, N. and Kettenmann, H. (2005) Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol., 64, 754-762.
20. Williams, K, Bar-Or, A., Ulvestad, E., Olivier, A., Antel, J.P. and Yong, V.W. (1992) Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J. Neuropathol. Exp. Neurol., 51, 538-549.
21. Ulvestad, E., Williams, K, Bjerkvig, R., Tiekotter, K, Antel, J. and Matre, R. (1994) Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J. Leukoc. Biol., 56, 732-740.
22. Ulvestad, E., Williams, K., Mork, S., Antel, J. and Nyland, H. (1994) Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J. Neuropathol. Exp. Neurol., 53, 492-501.
23. Saura, J., Tusell, J.M. and Serratosa, J. (2003) High-yield isolation of murine microglia by mild trypsinization. Glia, 44, 183-189.
24. Dasgupta, B., Dugan, L.L. and Gutmann, D.H. (2003) The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes. J. Neurosci., 23, 8949-8954.
25. Dasgupta, B., Yi, Y., Chen, D.Y., Weber, J.D. and Gutmann, D.H. (2005) Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res., 65, 2755-2760.
26. Kreutzberg, G.W. (1996) Microglia: A Sensor for Pathological Events in the CNS. Trends Neurosci., 19, 312-318.
27. Perry, V.H., Andersson, P.B. and Gordon, S. (1993) Macrophages and inflammation in the central nervous system. Trends Neurosci., 16, 268-273.
28. Badie, B., Schartner, J., Klaver, J. and Vorpahl, J. (1999) In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery, 44, 1077-1082.
29. Kaur, C., Sivakumar, V., Dheen, S.T. and Ling, E.A. (2006) Insulin-like growth factor I and Ii expression and modulation in amoeboid microglial cells by lipopolysaccharide and retinoic acid. Neuroscience, 138, 1233-1244.
30. Struve, J., Maher, P.C., Li, Y.Q., Kinney, S., Fehlings, M.G., Kuntz, C. and Sherman, L.S. (2005) Disruption of the hyaluronan-based extracellular matrix in spinal cord promotes astrocyte proliferation. Glia, 52, 16-24.
31. Isoyama, T., Thwaites, D., Selzer, M.G., Carey, R.I., Barbucci, R. and Lokeshwar, V.B. (2006) Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases. Glycobiology, 16, 11-21.
32. Cichowski, K., Santiago, S., Jardim, M., Johnson, B.W. and Jacks, T. (2003) Dynamic regulation of the Ras pathway via proteolysis of the Nf1 tumor suppressor. Genes Dev., 17, 449-454.
33. Lau, N., Feldkamp, M.M., Roncari, L, Loehr, A.H., Shannon, P., Gutmann, D.H. and Guha, A. (2000) Loss of neurofibromin is associated with activation of Ras/Mapk and Pi3-K/Akt signaling in a neurofibromatosis 1 astrocytoma. J. Neuropathol. Exp. Neurol., 59, 759-767.
34. Zhang, Y.Y., Vik, T.A., Ryder, J.W., Srour, E.F., Jacks, T., Shannon, K. and Clapp, D.W. (1998) Nf1 regulates hematopoietic progenitor cell growth Ras signaling in response to multiple cytokines. J. Exp. Med. 187, 1893-1902.
35. Campanella, M., Sciorati, C., Tarozzo, G. and Beltramo, M. (2002) Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke, 33, 586-592.
36. Fischer, H.G. and Reichmann, G. (2001) Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol., 166, 2717-2726.
37. Tikka, T., Fiebich, B.L., Goldsteins, G., Keinanen, R. and Koistinaho, J. (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci., 21, 2580-2588.
38. Wu, D.C., Jackson-Lewis, V., Vila, M., Tieu, K, Teismann, P., Vadseth, C., Choi, D.K., Ischiropoulos, H. and Przedborski, S. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of parkinson disease. J. Neurosci., 22, 1763-1771.
39. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T. and Koistinaho, J. (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl Acad Sci. USA 95, 15769-15774.
40. Hains, B.C. and Waxman, S.G. (2006) Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci., 26, 4308-4317.
41. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T. and Koistinaho, J. (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl Acad. Sci. USA 95, 15769-15774.
42. Yrjanheikki, J., Tikka, T., Keinanen, R., Goldsteins, G., Chan, P.H. and Koistinaho, J. (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl Acad. Sci. USA, 96, 13496-13500.
43. Gilbertson-Beadling, S., Powers, E.A., Stamp-Cole, M., Scott, P.S., Wallace, T.L., Copeland, J., Petzold, G., Mitchell, M., Ledbetter, S. and Poorman, R. (1995) The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism. Cancer Chemother. Pharmacol., 36, 418-424.
44. Tamargo, R.J., Bok, R.A. and Brem, H. (1991) Angiogenesis inhibition by minocycline. Cancer Res., 51, 672-675.
45. van Kempen, L.C., Ruiter, D.J., van Muijen, G.N. and Coussens, L.M. (2003) The tumor microenvironment: A critical determinant of neoplastic evolution. Eur. J. Cell. Biol., 82, 539-548.
46. Bhowmick, N.A., Neilson, E.G. and Moses, H.L. (2004) Stromal fibroblasts in cancer initiation and progression. Nature, 432, 332-337.
47. Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A. et al. (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell, 6, 17-32.
48. Rubin, J.B., Kung, A.L., Klein, R.S., Chan, J.A., Sun, Y., Schmidt, K., Kieran, M.W., Luster, A.D. and Segal, R.A. (2003) A small-molecule antagonist of Cxcr4 inhibits intracranial growth of primary brain tumors. Proc. Natl Acad. Sci. USA, 100, 13513-13518.
49. Cruz-Munoz, W., Kim, I. and Khokha, R. (2006) Timp-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis. Oncogene., 25, 650-655.
50. Birchmeier, C., Birchmeier, W., Gherardi, E. and Vande Woude, G.F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925.
51. Gold, L.I. (1999) The role for transforming growth factor-beta (Tgf-beta) in human cancer. Crit. Rev. Oncog., 10, 303-360.
52. Tucker, R.F., Shipley, G.D., Moses, H.L. and Holley, R.W. (1984) Growth inhibitor from Bsc-1 cells closely related to platelet type beta transforming growth factor. Science, 226, 705-707.
53. Hill, R., Song, Y., Cardiff, R.D. and Van Dyke, T. (2005) Selective evolution of stromal mesenchyme with P53 loss in response to epithelial tumorigenesis. Cell, 123, 1001-1011.
54. Mahgoub, N., Taylor, B.R., Gratiot, M., Kohl, N.E., Gibbs, J.B., Jacks, T. and Shannon, K.M. (1999) In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells. Blood., 94, 2469-2476.
55. Gitler, A.D., Kong, Y., Choi, J.K., Zhu, Y., Pear, W.S. and Epstein, J.A. (2004) Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia. Pediatr. Res., 55, 581-584.
56. Zhu, Y., Ghosh, P., Charnay, P., Burns, D.K. and Parada, L.F. (2002) Neurofibromas in Nf1: Schwann cell origin and role of tumor environment. Science, 296, 920-922.
57. Klein, R. and Roggendorf, W. (2001) Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: A double labeling study. Acta. Neuropathol. (Berl.), 101, 245-248.
58. Gutmann, D.H., Donahoe, J., Brown, T., James, C.D. and Perry, A. (2000) Loss of neurofibromatosis 1 (Nf1) gene expression in Nf1-associated pilocytic astrocytomas. Neuropathol. Appl. Neurobiol., 26, 361-367.
59. Berdel, W.E., de Vos, S., Maurer, J., Oberberg, D., von Marschall, Z., Schroeder, J.K., Li, J., Ludwig, W.D., Kreuser, E.D., Thiel, E. et al. (1992) Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit Protooncogene. Cancer Res., 52, 3498-3502.
60. Goswami, S., Sahai, E., Wyckoff, J.B., Cammer, M., Cox, D., Pixley, F.J., Stanley, E.R., Segall, J.E. and Condeelis, J.S. (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res., 65, 5278-5283.
61. O'Sullivan, C., Lewis, C.E., Harris, A.L. and McGee, J.O. (1993) Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet, 342, 148-149.
62. Lewis, C. and Murdoch, C. (2005) Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am. J. Pathol., 167, 627-635.
63. Weissenberger, J., Loeffler, S., Kappeler, A., Kopf, M., Lukes, A., Afanasieva, T.A., Aguzzi, A. and Weis, J. (2004) Il-6 is required for glioma development in a mouse model. Oncogene, 23, 3308-3316.
64. Enegd, B., King, J.A., Stylli, S., Paradiso, L., Kaye, A.H. and Novak, U. (2002) Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity. Neurosurgery, 50, 1311-1318.
65. Bettinger, L, Thanos, S. and Paulus, W. (2002) Microglia promote glioma migration. Acta. Neuropathol. (Berl.), 103, 351-355.
66. Woerner, B.M., Warrington, N.M., Kung, A.L., Perry, A. and Rubin, J.B. (2005) Widespread Cxcr4 activation in astrocycomas revealed by phospho-Cxcr4-specific antibodies. Cancer Res., 65, 11392-11399.
67. Munchhof, A.M., Li, F., White, H.A., Mead, L.E., Krier, T.R., Fenoglio, A., Li, X., Yuan, J., Yang, F.C. and Ingram, D.A. (2006) Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. Hum. Mol. Genet., 15, 1858-1869.
68. Dasgupta, B., Li, W., Perry, A. and Gutmann, D.H. (2005) Glioma formation in neurofibromatosis 1 reflects preferential activation of K-Ras in astrocytes. Cancer Res., 65, 236-245.
69. Lokeshwar, V.B., Young, M.J., Goudarzi, G., Iida, N., Yudin, A.I., Cherr, G.N. and Selzer, M.G. (1999) Identification of bladder tumor-derived hyaluronidase: Its similarity to Hyall. Cancer Res., 59, 4464-4470.
70. Pham, H.T., Block N.L. and Lokeshwar, V.B. (1997) Tumor-derived hyaluronidase: A diagnostic urine market for high-grade bladder cancer. Cancer Res., 57, 778-783.
71. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.